about
Environmental and state-level regulatory factors affect the incidence of autism and intellectual disabilityThe MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite StudyBenefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxineSuicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxineSample size determination for clustered count dataMeta-Analysis of Rare Binary Adverse Event Data.Longitudinal data analysis in support of functional stability concepts for leachate management at closed municipal landfills.Multiple imputation for harmonizing longitudinal non-commensurate measures in individual participant data meta-analysis.Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.Using clinical data to predict high-cost performance coding issues associated with pressure ulcers: a multilevel cohort model.On the psychometric validity of the domains of the PDSQ: an illustration of the bi-factor item response theory model.Missing Data in Longitudinal Trials - Part B, Analytic Issues.Missing Data in Longitudinal Clinical Trials Part A: Design and Conceptual Issues.Advances in analysis of longitudinal dataUsing Non-experimental Data to Estimate Treatment EffectsDevelopment of the CAT-ANX: a computerized adaptive test for anxiety.Post-approval drug safety surveillance.The statistics of suicide.Design and Analysis of Longitudinal Studies.Using computerized adaptive testing to reduce the burden of mental health assessment.A pharmacogenetic study of escitalopram in autism spectrum disordersGabapentin and suicide attempts.Multicenter development and validation of a risk stratification tool for ward patients.Varenicline, smoking cessation, and neuropsychiatric adverse events.Item Response Theory Approaches to Harmonization and Research SynthesisThe relationship between antidepressant prescription rates and rate of early adolescent suicide.Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.Association between leukotriene-modifying agents and suicide: what is the evidence?Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US.Using latent variable modeling and multiple imputation to calibrate rater bias in diagnosis assessment.Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents.Hypothesis testing, power and sample size determination for between group comparisons in fMRI experiments.Estimation and Classification of BOLD Responses Over Multiple Trials.Approaches to Mixed Methods Dissemination and Implementation Research: Methods, Strengths, Caveats, and Opportunities.Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge TrialPharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in AutismContextual predictors of mental health service use among children open to child welfare.Development of a computerized adaptive test for depressionAdolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.Mixed-effects Poisson regression analysis of adverse event reports: the relationship between antidepressants and suicide.
P50
Q21558515-57697C65-A710-4813-BE0B-B66240D325F6Q22242740-739F4336-9478-4717-A15C-78B79AE8A878Q24607720-08C5B957-AE36-49F6-B1E2-A818A3D72A8DQ24612175-DEEF9CAD-527C-491C-AE5E-0EF56A5D048EQ30617036-F88BF430-772F-45EF-9E3E-98441260282AQ30640167-7FDFA7D4-2CD3-4AA7-AE32-D77A601398E4Q30830323-F729AE22-589A-42AD-B34C-009707756D59Q30975676-1AC59CEF-A728-4400-A41B-871319B4B33EQ31117436-8ACFF620-4F40-42EA-A3A9-6D6D2D62702EQ31122367-672D002C-17D6-4F8A-A39C-3CA8EDA595BDQ33343742-9E79A859-4CD8-49A5-9B9F-70D06A9766D7Q33492294-D7201F65-7A4E-4F31-87F5-B04F2DB464E3Q33503655-7F571D6E-102B-407E-907E-D1EFA42D36E5Q33535446-E1BF76BC-A1C9-4616-B2F6-DA9E69899485Q33610053-A641DB6F-6296-4F61-B587-612F0513BC3DQ33738274-62A2FACF-AD75-4ACC-BF55-C8CB4341E77DQ33739346-00848CFB-B611-445D-9C6C-15BD0094F591Q33744415-8B69EE9E-3E2A-4905-BD47-87B8A7D8D937Q33909074-4C935CC3-F66F-48A3-A992-ADD63C40DF55Q34047630-92BB96B7-C1EB-4244-9A0D-84DEBE14B1D0Q34118665-11314490-094E-4A4D-9EA3-43955E59F37DQ34351244-FD955CD8-2ACF-40D1-9E99-AC2F3B19A04AQ34425920-19B95E88-67C9-4F6C-9654-24BDA8FB24B2Q34546833-418CE698-B078-4D9C-9ED7-D49A84295F48Q34572790-3A243342-26A3-42C0-98EB-1E8A3CC328EFQ34577873-DE4AF79C-1444-4BED-AC0C-AF9B66598C18Q34582162-8E0364C7-7FE7-4F53-8257-07FC5E39374CQ34630067-D1AD9EEE-5DCA-4BA7-898D-F164A0B70C8AQ34633422-83E0010C-2103-49B0-A122-F4758EC66EA6Q34679817-EB859CB5-8716-44AD-8EA5-01C5499C7E9BQ35032482-461C9EDE-BD39-43A7-BD65-49015A92002DQ35096929-9689B7FE-B9E0-4447-8BE5-95FA7373DB39Q35098253-257EDA0D-8D7E-4098-9D3F-037C88B5CF61Q35186098-9316214A-C31B-4660-8C51-1F8F117100D8Q35889773-1018398D-C3D2-463C-8D5C-F41BE5921731Q35982186-1123BE0B-730D-4BFE-B363-3AFF93458944Q36015142-96EBDEC6-4CCB-4334-9787-AB7ADD430C4CQ36551041-1452823F-4F01-49A1-80EF-1670F4FBF764Q36659092-D8993C2F-3AD1-4DDF-81A3-576A9E824125Q36711090-0B78982B-49B6-4EB6-ADA1-AD7B6D406421
P50
description
American biostatistician at University of Chicago working with psychiatry
@en
Amerikaans onderzoeker (1955-)
@nl
name
Robert D. Gibbons
@ast
Robert D. Gibbons
@ca
Robert D. Gibbons
@da
Robert D. Gibbons
@de
Robert D. Gibbons
@en
Robert D. Gibbons
@es
Robert D. Gibbons
@fr
Robert D. Gibbons
@ga
Robert D. Gibbons
@nl
Robert D. Gibbons
@sl
type
label
Robert D. Gibbons
@ast
Robert D. Gibbons
@ca
Robert D. Gibbons
@da
Robert D. Gibbons
@de
Robert D. Gibbons
@en
Robert D. Gibbons
@es
Robert D. Gibbons
@fr
Robert D. Gibbons
@ga
Robert D. Gibbons
@nl
Robert D. Gibbons
@sl
altLabel
Robert D Gibbons
@da
Robert D Gibbons
@de
Robert D Gibbons
@en
prefLabel
Robert D. Gibbons
@ast
Robert D. Gibbons
@ca
Robert D. Gibbons
@da
Robert D. Gibbons
@de
Robert D. Gibbons
@en
Robert D. Gibbons
@es
Robert D. Gibbons
@fr
Robert D. Gibbons
@ga
Robert D. Gibbons
@nl
Robert D. Gibbons
@sl
P1006
P214
P244
P1006
P101
P19
P1960
jkK_OWsAAAAJ
P21
P213
0000 0001 0905 8610
P214
P244
P31
P569
1955-06-28T00:00:00Z
P734
P735
P7859
lccn-n83168257